Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Aleman

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
Infectious Diseases (London, England)|September 25, 2024
Long-term risk of HCC in a DAA-treated national hepatitis C cohort, and a proposed risk scoreCharlotte Lybeck, Daniel Bruce, Robert Szulkin, et al.
Scandinavian Journal of Gastroenterology|December 18, 2014
The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategiesAnn-Sofi Duberg, Sarah Blach, Karolin Falconer, et al.
Ejhaem|January 27, 2025
Uptake of the first to fifth doses of coronavirus disease 2019 vaccine in individuals with chronic lymphocytic leukaemia: A nationwide cohort study in SwedenPontus Hedberg, Lisa Blixt, Fredrik Granath, et al.
Scandinavian Journal of Infectious Diseases|June 13, 2009
Hepatitis C infection among injection drug users in Stockholm Sweden: prevalence and genderChrister Lidman, Lillebil Norden, Martin Kåberg, et al.
BMC Infectious Diseases|November 26, 2022
Monitoring the progress towards the elimination of hepatitis B and C in Sweden: estimation of core indicators for 2015 and 2018Soledad Colombe, Maria Axelsson, Soo Aleman, et al.
Scandinavian Journal of Gastroenterology|February 14, 2020
Sustained clinical benefit, improved quality of life, and reduced intestinal surgery from maintenance infliximab treatment in inflammatory bowel disease<sup></sup>Akter Hossain, Mikael Lördal, Annika E Olsson, et al.
European Journal of Gastroenterology & Hepatology|November 22, 2018
Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patientsCharlotte Lybeck, Erwin D Brenndörfer, Matti Sällberg, et al.
Scandinavian Journal of Infectious Diseases|April 18, 2012
Treatment of hepatitis C virus infection in adults and children: updated Swedish consensus recommendationsMartin Lagging, Ann-Sofi Duberg, Rune Wejstål, et al.
Journal of Viral Hepatitis|July 22, 2021
Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studiesHabiba Kamal, Romina Fornes, Johanna Simin, et al.
Gut|August 5, 2011
Hepatitis C virus non-structural 3/4A protein interferes with intrahepatic interferon-γ productionErwin Daniel Brenndörfer, Anette Brass, Jonas Söderholm, et al.
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
Infectious Diseases (London, England)|September 25, 2024
Long-term risk of HCC in a DAA-treated national hepatitis C cohort, and a proposed risk scoreCharlotte Lybeck, Daniel Bruce, Robert Szulkin, et al.
Scandinavian Journal of Gastroenterology|December 18, 2014
The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategiesAnn-Sofi Duberg, Sarah Blach, Karolin Falconer, et al.
Ejhaem|January 27, 2025
Uptake of the first to fifth doses of coronavirus disease 2019 vaccine in individuals with chronic lymphocytic leukaemia: A nationwide cohort study in SwedenPontus Hedberg, Lisa Blixt, Fredrik Granath, et al.
Scandinavian Journal of Infectious Diseases|June 13, 2009
Hepatitis C infection among injection drug users in Stockholm Sweden: prevalence and genderChrister Lidman, Lillebil Norden, Martin Kåberg, et al.
BMC Infectious Diseases|November 26, 2022
Monitoring the progress towards the elimination of hepatitis B and C in Sweden: estimation of core indicators for 2015 and 2018Soledad Colombe, Maria Axelsson, Soo Aleman, et al.
Scandinavian Journal of Gastroenterology|February 14, 2020
Sustained clinical benefit, improved quality of life, and reduced intestinal surgery from maintenance infliximab treatment in inflammatory bowel disease<sup></sup>Akter Hossain, Mikael Lördal, Annika E Olsson, et al.
European Journal of Gastroenterology & Hepatology|November 22, 2018
Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patientsCharlotte Lybeck, Erwin D Brenndörfer, Matti Sällberg, et al.
Scandinavian Journal of Infectious Diseases|April 18, 2012
Treatment of hepatitis C virus infection in adults and children: updated Swedish consensus recommendationsMartin Lagging, Ann-Sofi Duberg, Rune Wejstål, et al.
Journal of Viral Hepatitis|July 22, 2021
Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studiesHabiba Kamal, Romina Fornes, Johanna Simin, et al.
Gut|August 5, 2011
Hepatitis C virus non-structural 3/4A protein interferes with intrahepatic interferon-γ productionErwin Daniel Brenndörfer, Anette Brass, Jonas Söderholm, et al.
Pageof 15